GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Rosetta Genomics ROSGQ · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Rosetta Genomics — daily ROSGQ Delayed
Market value
$174
Last close × shares
Volume
1.6k
Shares, 30 Oct 2026

About Rosetta Genomics

Its shares trade under the ticker ROSGQ. It has been listed since 27 February 2007. In the fiscal year to 31 December 2016, it reported revenue of $9.2m and a net loss of $16.2m. At that date it held total assets of $12.0m and shareholders' equity of $4.4m.

Rosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research services. The firm is marketing and selling over four diagnostic tests based on its microRNA technologies, which include RosettaGX Cancer Origin, mi-LUNG, mi-KIDNEY and RosettaGX Reveal. The firm's therapeutic pipeline consists of the projects, which include Rimonim Consortium and Magneton Project. The firm focuses on developing diagnostic assay, RosettaGX Reveal V2. The company is also focusing on developing Bladder cancer risk stratification.

Figures and description from our data supplier, not checked against the company's own report.

More about Rosetta Genomics →

Latest on Rosetta Genomics

Our reporting

We have not reported on Rosetta Genomics yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Rosetta Genomics's ticker?

Rosetta Genomics trades as ROSGQ on its US listing, under ISIN IL0011026494.

What was Rosetta Genomics's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.